// App-Quantinova.ai

102 : Characterizing the T cell repertoire in lung squamous cell premalignancy and its association with lesion outcome.

Researchers

Presenter

  • Asaf Maoz

Principal Investigators

  • Carter Merenstein

  • Sarah Mazzilli

  • Joshua Campbell

  • Gang Liu

  • Sherry Zhang

  • Samjot S. Dhillon

  • Christopher Stevenson

  • Mary E. Reid

  • Marc Lenburg

  • Spira Avi

  • Jennifer Beane

Medical Centers

  • Division of General Pediatrics, Boston University School of Medicine/Boston Medical Center, Boston, MA

  • Tufts University School of Medicine, Boston, MA

  • Roswell Park Cancer Institute, Buffalo, NY

  • Janssen Pharmaceuticals, London, United Kingdom,

  • Roswell Park Comprehensive Cancer Center, Buffalo, NY

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • Promyelocytic Leukemia

  • T-cell receptor

Drug/Treatment

  • Carbetimer

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A